
IRIDEX fell about 19% premarket (27% after hours) after Q3 revenue of $10.16M missed the $12.64M estimate by ~20% and fell 19% year over year. Management also cut full-year 2026 revenue guidance to $46-48M from $51-53M, citing weak demand in Europe and Asia, distributor destocking and regulatory hurdles.